Evidence map›Paper›PMID 25040785›Full record

ArticleAging cell2014

mTORC2-SGK-1 acts in two environmentally responsive pathways with opposing effects on longevity.

Masaki Mizunuma, Elke Neumann-Haefelin, Natalie Moroz, Yujie Li, T Keith Blackwell

Open access · goldAbstract read
In one paragraph

Article in Aging cell, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 96 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Autophagy: A Double-Edged Sword in the Aging ofInternational journal of molecular sciences · 2026
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. High-content phenotypic analysis ofbioRxiv : the preprint server for biology · 2024
    Article
  14. Review
  15. A novel gain-of-function mutation inmicroPublication biology · 2024
    Article
  16. Review
  17. The role of nutrition and oxidative stress as aging factors inJournal of clinical biochemistry and nutrition · 2023
    Article
  18. Lab on a chip · 2023
    Article
  19. Review
  20. Targeting mTOR for Anti-Aging and Anti-Cancer Therapy.Molecules (Basel, Switzerland) · 2023
    Review

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 3 countries.

Masaki MizunumaJoslin Diabetes Center, Harvard Stem Cell Institute, Harvard Medical School Department of Genetics, Boston, MA, 02215, USA; Department of Molecular Biotechnology, Graduate School of Advanced Sciences of Matter, Hiroshima University, Higashi-Hiroshima, 739-8530, Japan.
Elke Neumann-Haefelin
Natalie Moroz
Yujie Li
T Keith Blackwell
Harvard Stem Cell Institute · USHarvard University · USUniversity Medical Center Freiburg · DE

Funding

SPECIAL ASSAY COREP30DK036836 · NIDDK · JOSLIN DIABETES CENTER · PI JEAN E. SCHAFFER · 1986 to 2026
$50.5M
TRAINING IN DIABETES AND METABOLISMT32DK007260 · NIDDK · JOSLIN DIABETES CENTER · PI LAURIE J GOODYEAR · 1986 to 2026
$13.6M
SKN-1 Regulation and Oxidative Stress Resistance in C. elegansR01GM062891 · NIGMS · JOSLIN DIABETES CENTER · PI BLACKWELL, T KEITH · 2001 to 2016
$5.6M
NIDDK NIH HHS DK036836NIDDK NIH HHS P30 DK036836NIDDK NIH HHS T32 DK007260NIGMS NIH HHS GM062891NIGMS NIH HHS R01 GM062891
6 · The paper itself

Abstract

The nematode worm Caenorhabditis elegans provides a powerful system for elucidating how genetic, metabolic, nutritional, and environmental factors influence aging. The mechanistic target of rapamycin (mTOR) kinase is important in growth, disease, and aging and is present in the mTORC1 and mTORC2 complexes. In diverse eukaryotes, lifespan can be increased by inhibition of mTORC1, which transduces anabolic signals to stimulate protein synthesis and inhibit autophagy. Less is understood about mTORC2, which affects C. elegans lifespan in a complex manner that is influenced by the bacterial food source. mTORC2 regulates C. elegans growth, reproduction, and lipid metabolism by activating the SGK-1 kinase, but current data on SGK-1 and lifespan seem to be conflicting. Here, by analyzing the mTORC2 component Rictor (RICT-1), we show that mTORC2 modulates longevity by activating SGK-1 in two pathways that affect lifespan oppositely. RICT-1/mTORC2 limits longevity by directing SGK-1 to inhibit the stress-response transcription factor SKN-1/Nrf in the intestine. Signals produced by the bacterial food source determine how this pathway affects SKN-1 and lifespan. In addition, RICT-1/mTORC2 functions in neurons in an SGK-1-mediated pathway that increases lifespan at lower temperatures. RICT-1/mTORC2 and SGK-1 therefore oppose or accelerate aging depending upon the context in which they are active. Our findings reconcile data on SGK-1 and aging, show that the bacterial microenvironment influences SKN-1/Nrf, mTORC2 functions, and aging, and identify two longevity-related mTORC2 functions that involve SGK-regulated responses to environmental cues.

Indexed as

AnimalsCaenorhabditis elegansImmediate-Early ProteinsLongevityMechanistic Target of Rapamycin Complex 2MicrobiotaMultiprotein ComplexesPhosphorylationProtein Serine-Threonine KinasesSerum-Glucocorticoid Regulated KinasesSignal TransductionTOR Serine-Threonine KinasesTranscription FactorsImmediate-Early ProteinsMechanistic Target of Rapamycin Complex 2Multiprotein ComplexesProtein Serine-Threonine KinasesSerum-Glucocorticoid Regulated KinasesTOR Serine-Threonine KinasesTranscription FactorsagingmicrobiomemTORC2rictorserum- and glucocorticoid-regulated kinaseSKN-1/Nrf

Identifiers

PMID25040785
PMCPMC4172656
OpenAlexW2138012043

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.